Improved discrimination in the detection of neural tube defects: five biochemical tests compared.
Five biochemical tests, which have been proposed as possible adjuncts to the measurement of amniotic fluid alphafetoprotein for the identification of neural tube defects, have been measured in 49 normal and 46 neural tube defect affected pregnancies. One test, the alphafetoprotein component non-reactive with concanavalin A, was ineffective in differentiating normal and abnormal. The remaining four procedures, the activity of acetyl and total cholinesterase, the concentration of alpha 2 macroglobulin and the electrophoretic identification of acetyl cholinesterase effectively separated the normal and abnormal populations. The relative merits of these four latter tests in the evaluation of false positive and false negative amniotic fluid alphafetoprotein results, as well as in liquor samples with high alphafetoprotein levels associated with abnormalities not of neural origin, are discussed.
D000030:Abortion, Missed / Q000378:metabolism; D000110:Acetylcholinesterase / Q000378:metabolism; D000653:Amniotic Fluid / Q000378:metabolism*; D002802:Cholinesterases / Q000378:metabolism*; D003208:Concanavalin A; D005260:Female; D006554:Hernia, Umbilical / Q000378:metabolism; D006801:Humans; D009436:Neural Tube Defects / Q000175:diagnosis*; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D000509:alpha-Fetoproteins / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000378:metabolism*
D000509:alpha-Fetoproteins; D000511:alpha-Macroglobulins; D003208:Concanavalin A; D000110:Acetylcholinesterase; D002802:Cholinesterases